Epigenetic Clocks and Their Prospective Application in the Complex Landscape of Aging and Alzheimer’s Disease
Authors:
- Annamaria CerantonioACAnnamaria Cerantonio
- Beatrice Maria GrecoBGBeatrice Maria Greco
- Luigi CitrignoLCLuigi Citrigno
- Selene De BenedittisSBSelene De Benedittis
- Antonio QualtieriAQAntonio Qualtieri
- Raffaele MalettaRMRaffaele Maletta
- Alberto MontesantoAlberto Montesanto
- Giuseppe PassarinoGPGiuseppe Passarino
- Patrizia SpadaforaPSPatrizia Spadafora
- Francesca CavalcantiFCFrancesca Cavalcanti
Open Access
Abstract
Nowadays, scientists are making efforts to elucidate the mechanisms involved in the phenotypic changes underlying the aging process in order to develop favorable therapeutical interventions. Epigenetic modifications, in particular DNA methylation, play a crucial role in the aging process, and this parameter has been used to set epigenetic clocks, algorithms that predict an individual’s biological age based on a defined set of CpGs. In this review, we focus on the most recent literature to discuss the use of epigenetic clocks in the context of cognitive decline and dysregulation of Alzheimer’s disease (AD)-related gene expression. We have summarized all published scientific papers in which epigenetic clocks have been applied to measure age acceleration in blood and brain specimens from patients affected with AD. Progressive age acceleration, consistent with a specific DNA methylation signature, was observed in patients affected by AD, and it was correlated with the onset of complex diseases, mitochondrial alterations, dementia and cognitive decline, even in the early stages of these conditions. The use of epigenetic clocks might be a valuable biomarker to enable an earlier identification of ideal measures to reverse modifications caused by aging and to mitigate multiple aspects of disease/aging mechanisms.Keywords
Funding Information
- Next Generation EU, in the context of the National Recovery and Resilience Plan, Investment PE8—Project Age-It: “Ageing Well in an Ageing Society” (DM 1557 11.10.2022)
- Next Generation EU (DM 1557 11.10.2022)
This publication has 84 references indexed in Scilit:
- Biomarkers of aging for the identification and evaluation of longevity interventionsCell, 2023
- DNA methylation: The epigenetic mechanism of Alzheimer's diseaseIbrain, 2023
- Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volumeGeroScience, 2022
- The role of DNA methylation and hydroxymethylation in immunosenescenceAgeing Research Reviews, 2019
- The epigenetic landscape of age-related diseases: the geroscience perspectiveBiogerontology, 2017
- Altered Mitochondrial DNA Methylation Pattern in Alzheimer Disease–Related Pathology and in Parkinson DiseaseThe American Journal of Pathology, 2016
- Molecular and biological hallmarks of ageingBritish Journal of Surgery, 2016
- Geroscience: Linking Aging to Chronic DiseaseCell, 2014
- The Hallmarks of AgingCell, 2013
- Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brainBiological Psychiatry, 2004